Table 2.
Correlation of urinary biomarkers with selected ETS, VOC compounds, parent PAH and non-parent PAH personal exposures (Pearson R, logged database) (sample size VOC≤86, PAH≤68).
| Cotinine | trans-3′-Hydroxycotinine | 2-Naphthol | 2-Hydroxyfluorene | 1-Hydroxypyrene | |
|---|---|---|---|---|---|
| VOC selected compounds | |||||
| 3-Ethenyl Pyridine | 0.75a** | 0.64a** | −0.09 | −0.020 | −0.080 |
| Naphthalene (gas phase) | 0.050 | −0.050 | 0.030 | 0.00 | −0.060 |
| 1,3-Butadiene | 0.47a** | 0.44a** | 0.070 | 0.15 | 0.15 |
| PAH parent compounds | |||||
| Fluorene | −0.23 | 0.11 | −0.73 | −0.26 | 0.48 |
| Phenanthrene | 0.11 | 0.04 | −0.13 (0.90b) | 0.12 | 0.10 |
| Pyrene | 0.070 | 0.090 | 0.17 (0.88b) | 0.31a* | 0.18 |
| PAH non-parent compounds | |||||
| Benzo(a)anthracene | 0.35a* | 0.32a* | 0.20 | 0.17 | −0.12 |
| Chrysene | 0.55a** | 0.52a** | 0.30a*(0.76b) | 0.28 | 0.11 |
| Benzo(b) fluoranthene | 0.42a** | 0.38a** | 0.15 | 0.17 | 0.10 |
| Benzo(k) fluoranthene | 0.45a** | 0.42a** | 0.16 | 0.26 | 0.15 |
| Benzo(a)pyrene | 0.38a* | 0.36a* | 0.22 | 0.28 | 0.14 |
| Indeno(1,2,3-cd)pyrene | 0.060 | 0.090 | 0.16 | 0.14 | 0.050 |
| Dibenz(a,h)anthracene | 0.37a* | 0.32a* | 0.080 | 0.070 | 0.00 |
| Benzo(ghi)perylene | 0.30a* | 0.31a* | 0.20 | 0.16 | 0.12 |
| Coronene | 0.23 | 0.21 | 0.010 | 0.060 | 0.080 |
| Sum of low MW PAH [Naph-An] | 0.17 | 0.11 | −0.080 (0.92b) | 0.080 | 0.080 |
| Sum of medium MW PAH [Fluo-Chry] | 0.27a* | 0.31a* | 0.33a*(0.88b) | 0.26a* | 0.060 |
| Sum of high MW PAH [B(b)F-Cor] | 0.37a* | 0.37a* | 0.24 | 0.21 | 0.15 |
| Sum of 16PAH [Naph-B(ghi)P] | 0.26a* | 0.31a* | 0.24a*(0.84b) | 0.25a* | 0.13 |
Bold Values represent correlations statistically significant at the 0.05 level (2-tailed).
The correlation between the variables is statistically significant in a 2-tailed test at the 0.05 level (*) or at the 0.01 level (**).
The correlation between the variables is statistically significant in a 2-tailed test at the 0.05 level only in the high-ETS subset (N=9).